— Know what they know.
Not Investment Advice
Also trades as: MED.SW (SIX) · $vol 1M

MDRSF OTC

Medartis Holding AG
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +15.0% 1Y: +72.5% 3Y: +94.9% 5Y: +140.8%
$115.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 46 · $1.4B mcap · 4M float · 0.0045% daily turnover · Short 100% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.4B
52W Range66.68-115
Volume217
Avg Volume183
Beta1.17
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMatthias Schupp
Employees1,337
SectorHealthcare
IndustryMedical - Devices
IPO Date2020-01-17
Hochbergerstrasse 60E
Basel, BS 4057
CH
41 61 633 34 34
About Medartis Holding AG

Medartis Holding AG is a Switzerland-based medical technology firm, founded in 1997 and headquartered in Basel. The company specializes in the global creation, production, and distribution of advanced implant solutions. These sophisticated medical devices are engineered to support the surgical repair and stabilization of bone fractures, specifically targeting injuries in both upper and lower limbs, as well as intricate cranio-maxillofacial surgeries. Operating under its prominent APTUS and MODUS brands, Medartis provides a comprehensive array of osteosynthesis instruments. These specialized tools and implants are designed for a wide spectrum of anatomical applications, including procedures involving the hand, wrist, elbow, shoulder, foot, and ankle, alongside the mandible, midface, orthognathic, and cranial regions. Medartis serves a diverse international client base, including surgeons, hospitals, medical centers, and various group purchasing organizations.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms